CS logo
small CS logo
Fondazione IRCCS Ospedale Maggiore Policlinico; Gastroenterologia

Milano, Lombardia, Italy
Hospital in Milan
Via Francesco Sforza, 35, 20122 Milano MI
900 Beds

About Fondazione IRCCS Ospedale Maggiore Policlinico; Gastroenterologia


The Policlinico of Milan also known as Ospedale Maggiore di Milano or Ca' Granda Ospedale Maggiore Policlinico, is one of the oldest hospitals in Italy, founded by Duke Francesco Sforza in 1456. Today it is a modern hospital with 900 beds, with wards for adults, pregnant women and children.
There are 900 beds in Fondazione IRCCS Ospedale Maggiore Policlinico; Gastroenterologia.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Fondazione IRCCS Ospedale Maggiore Policlinico; Gastroenterologia


During the past decade, Fondazione IRCCS Ospedale Maggiore Policlinico; Gastroenterologia conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Fondazione IRCCS Ospedale Maggiore Policlinico; Gastroenterologia


According to Clinical.Site data, the most researched conditions in "Fondazione IRCCS Ospedale Maggiore Policlinico; Gastroenterologia" are "Hepatitis B, Chronic" (3 trials), "Carcinoma, Hepatocellular" (2 trials), "Ulcerative Colitis" (2 trials), "Glioblastoma" (1 trials) and "Unresectable Hepatocellular Carcinoma" (1 trials). Many other conditions were trialed in "Fondazione IRCCS Ospedale Maggiore Policlinico; Gastroenterologia" in a lesser frequency.

Clinical Trials Intervention Types at Fondazione IRCCS Ospedale Maggiore Policlinico; Gastroenterologia


Most popular intervention types in "Fondazione IRCCS Ospedale Maggiore Policlinico; Gastroenterologia" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Atezolizumab" (2 trials), "Bevacizumab" (2 trials), "GC33" (1 trials) and "Interleukin 28B testing" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Fondazione IRCCS Ospedale Maggiore Policlinico; Gastroenterologia


The vast majority of trials in "Fondazione IRCCS Ospedale Maggiore Policlinico; Gastroenterologia" are 9 trials for "All" genders.

Clinical Trials Status at Fondazione IRCCS Ospedale Maggiore Policlinico; Gastroenterologia


Currently, there are NaN active trials in "Fondazione IRCCS Ospedale Maggiore Policlinico; Gastroenterologia". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Fondazione IRCCS Ospedale Maggiore Policlinico; Gastroenterologia, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Fondazione IRCCS Ospedale Maggiore Policlinico; Gastroenterologia, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".